Apollo Hospitals Enterprise Limited
Updates
Apollo Hospitals Enterprise Limited has informed the Exchange regarding 'Certificate under Regulation 74(5) for the period ended 30th September 2026'.
23
total announcements
APOLLOHOSP.NS · 15 min delayed
Key Stats · Yahoo Finance · as of 14 Oct 2026
Market Cap
₹1.13 L Cr
P/E (TTM)
52.5
P/E (Forward)
36.1
EPS (TTM)
₹149.98
52W Low
₹6,696.50
52W High
₹9,070.50
Dividend Yield
0.26%
Beta
0.17
Price / Book
11.9
Debt / Equity
85.1
Revenue (TTM)
₹26,430 Cr
Gross Margin
35.21%
Operating Margin
12.17%
Apollo Hospitals Enterprise Limited
Apollo Hospitals Enterprise Limited has informed the Exchange regarding 'Certificate under Regulation 74(5) for the period ended 30th September 2026'.
Apollo Hospitals Enterprise Limited
Apollo Hospitals Enterprise Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015, ahead of unaudited financial results for the three and six months ending on 30th September 2026.
Apollo Hospitals Enterprise Limited
Apollo Hospitals Enterprise Limited has informed the Exchange about General Updates regarding the submission of newspaper advertisements for the transfer of shares to the Investor Education and Protection Fund (IEPF) pursuant to applicable statutory provisions.
Apollo Hospitals Enterprise Limited
Apollo Hospitals Enterprise Limited has informed the Exchange about the proceedings and voting results of the 45th Annual General Meeting (AGM) held on August 25, 2026, through video conference.
Apollo Hospitals Enterprise Limited
Apollo Hospitals Enterprise Limited has informed the Exchange regarding Proceedings of Annual General Meeting held on August 25, 2026, and voting results along with copy of scrutinizers report together with copy of minutes.
Apollo Hospitals Enterprise Limited
Apollo Hospitals Enterprise Limited has informed the Exchange about the transcript of the presentation on unaudited financial results for the three months ended June 30, 2026, available on the Company's website.
Apollo Hospitals Enterprise Limited
Apollo Hospitals Enterprise Limited has informed the Exchange about the availability of the audio recording of the Analyst call on financial results for the three months ended June 30, 2026, on the Company's website.
Apollo Hospitals Enterprise Limited
Apollo Hospitals Enterprise Limited has informed the Exchange about Investor Presentation for the three months ended June 30, 2026, in compliance with Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Apollo Hospitals Enterprise Limited
Apollo Hospitals Enterprise Limited has informed the Exchange about Presentation of Investor Relations for Q1 FY27, disclosing earnings update for the quarter ended June 30, 2026.
Apollo Hospitals Enterprise Limited
Apollo Hospitals Enterprise Limited has informed the Exchange about General Updates, including the approval of unaudited financial results, appointment of new statutory auditors, and grant of stock options under the Apollo ESOP Plan 2024.
Apollo Hospitals Enterprise Limited
Apollo Hospitals Enterprise Limited has informed the Exchange regarding a press release dated August 12, 2026, titled "Apollo Hospitals Q1FY27 Results". The company has approved the unaudited financial results for the three months ended June 30, 2026, and appointed M/s Price Waterhouse Chartered Accountants LLP as Statutory Auditors for a term of five years. Additionally, the company has taken note of the proposed transfer of undertaking by Apollo Healthco Limited to its wholly owned subsidiary and granted additional stock options to new employees.
Apollo Hospitals Enterprise Limited
Apollo Hospitals Enterprise Limited has submitted its financial results for the period ended June 30, 2026, and approved the appointment of new statutory auditors. The company also announced the transfer of a subsidiary's undertaking and the grant of additional stock options under its employee stock option plan.
Apollo Hospitals Enterprise Limited
Apollo Hospitals Enterprise Limited has informed the Exchange about General Updates related to the 45th Annual General Meeting and e-voting information.
Apollo Hospitals Enterprise Limited
Apollo Hospitals Enterprise Limited has informed the Exchange about General Updates, including the submission of Notice of 45th Annual General Meeting (AGM) and Annual Report for the FY 2025-2026, and the confirmation of Interim Dividend and approval for Declaration of Final Dividend.
Apollo Hospitals Enterprise Limited
Apollo Hospitals Enterprise Limited has informed the Exchange regarding Notice of Annual General Meeting to be held on August 25, 2026, to confirm payment of Interim Dividend and to declare final dividend on Equity Shares for the financial year ended March 31, 2026.
Apollo Hospitals Enterprise Limited
Apollo Hospitals Enterprise Limited has scheduled a conference call for analysts/investors to discuss the unaudited financial results for the three months ended June 30, 2026. The call will be held on August 13, 2026, at 3:00 PM IST.
Apollo Hospitals Enterprise Limited
Apollo Hospitals Enterprise Limited has informed the Exchange regarding 'Certificate under Regulation 74(5) for the period ended 30th June 2026'.
Apollo Hospitals Enterprise Limited
Apollo Hospitals Enterprise Limited has informed the Exchange about Scheme of Arrangement. The company has passed the resolutions for the Scheme with requisite majority at their respective meetings.
Apollo Hospitals Enterprise Limited
Apollo Hospitals Enterprise Limited has submitted the Exchange a copy Scrutinizer's report of Court Convened General Meeting held on Jun 24, 2026. The company has informed the Exchange regarding voting results of the meeting of the equity shareholders, secured creditors, and unsecured creditors.
Apollo Hospitals Enterprise Limited
Apollo Hospitals Enterprise Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015. The trading window will remain closed from July 1, 2026, till 48 hours after the announcement/declaration of the unaudited financial results for the quarter ending on June 30, 2026.